Orthofix Medical Inc. (OFIX)
2025-06-30 | 2024-09-30 | |||
|---|---|---|---|---|
| Net sales | 203,121 | - | ||
| Cost of sales | 63,588 | 61,553 | ||
| Net sales | - | 196,606 | ||
| Gross profit | 139,533 | 135,053 | ||
| Acquisition-related amortization, impairment, and remeasurement (note 11) | 3,109 | - | ||
| Research and development | 15,934 | 17,294 | ||
| Sales, general, and administrative | 136,493 | - | ||
| Acquisition related amortization and remeasurement | - | 6,521 | ||
| General and administrative expense, total | - | 33,561 | ||
| Selling and marketing expense, total | - | 96,576 | ||
| Operating loss | -16,003 | -18,899 | ||
| Interest expense, net | -3,950 | -5,210 | ||
| Other income (expense), net | 5,730 | -2,528 | ||
| Loss before income taxes | -14,223 | -26,637 | ||
| Income tax benefit (expense) | -142 | 751 | ||
| Net loss | -14,081 | -27,388 | ||
| Currency translation adjustment | 3,464 | 1,829 | ||
| Other comprehensive income (loss), before tax | 3,464 | 1,829 | ||
| Other comprehensive income (loss), net of tax | 3,464 | 1,829 | ||
| Comprehensive loss | -10,617 | -25,559 | ||
| Earnings per share, basic | -0.36 | -0.71 | ||
| Earnings per share, diluted | -0.36 | -0.71 | ||
| Weighted average number of shares outstanding, basic | 39,501,000 | 38,488,000 | ||
| Weighted average number of shares outstanding, diluted | 39,501,000 | 38,488,000 | ||